Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Rossi

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Pathology|December 14, 1999
Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasmsR Horie, V Gattei, K Ito, et al.
Blood|March 15, 1997
CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid originV Gattei, M Degan, A Gloghini, et al.
Biotherapy (Dordrecht, Netherlands)|May 20, 1998
Hodgkin's disease: a disorder of dysregulated cellular cross-talkA Pinto, V Gattei, V Zagonel, et al.
Blood|April 15, 1997
Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironmentV Gattei, A Celetti, A Cerrato, et al.
Leukemia|March 22, 2017
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated componentsF Pozzo, T Bittolo, E Vendramini, et al.
Leukemia|July 14, 2015
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulationF Pozzo, T Bittolo, F Arruga, et al.
Leukemia|September 23, 2017
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathwaysD Benedetti, E Tissino, F Pozzo, et al.
Leukemia|April 26, 2016
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemiaM Dal Bo, P Bulian, R Bomben, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The American Journal of Pathology|December 14, 1999
Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasmsR Horie, V Gattei, K Ito, et al.
Blood|March 15, 1997
CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid originV Gattei, M Degan, A Gloghini, et al.
Biotherapy (Dordrecht, Netherlands)|May 20, 1998
Hodgkin's disease: a disorder of dysregulated cellular cross-talkA Pinto, V Gattei, V Zagonel, et al.
Blood|April 15, 1997
Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironmentV Gattei, A Celetti, A Cerrato, et al.
Leukemia|March 22, 2017
NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated componentsF Pozzo, T Bittolo, E Vendramini, et al.
Leukemia|July 14, 2015
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulationF Pozzo, T Bittolo, F Arruga, et al.
Leukemia|September 23, 2017
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathwaysD Benedetti, E Tissino, F Pozzo, et al.
Leukemia|April 26, 2016
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemiaM Dal Bo, P Bulian, R Bomben, et al.
Pageof 5